Sharon Davis, | |
21 Wildberry Dr, Rocky Mount, NC 27804-7723 | |
(252) 314-3158 | |
Not Available |
Full Name | Sharon Davis |
---|---|
Gender | Female |
Speciality | Private Vehicle |
Location | 21 Wildberry Dr, Rocky Mount, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780306506 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Sharon Davis, 21 Wildberry Dr, Rocky Mount, NC 27804-7723 Ph: (252) 314-3158 | Sharon Davis, 21 Wildberry Dr, Rocky Mount, NC 27804-7723 Ph: (252) 314-3158 |
News Archive
Celldex Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2010. Celldex reported a net loss of $6.6 million, or $0.21 per share, for the first quarter of 2010 compared to a net loss of $7.7 million, or $0.49 per share, for the first quarter of 2009. At March 31, 2010, Celldex reported cash, cash equivalents and marketable securities of $75.4 million, which the Company believes will be sufficient to meet estimated working capital requirements and fund operations into 2012.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, today announced the launch of the DaVita Phosphorus Challenge, an online resource designed to serve as a core learning tool for CKD and dialysis patients.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
Young children may be missing out on 'pretend' games like pirates and spacemen due to the demands of the school curriculum, according to research funded by the Economic and Social Research Council (ESRC).
Blocking the action of a particular protein in our skin could improve the treatment of skin cancers, according to a study published in Oncogene yesterday by Philippe Roux, a researcher at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC).
› Verified 7 days ago